Your browser doesn't support javascript.
loading
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study.
Shui, Irene M; Liu, Xiao Qiao; Zhao, Qing; Kim, Seung Tae; Sun, Yuan; Yearley, Jennifer H; Choudhury, Tasmiah; Webber, Andrea L; Krepler, Clemens; Cristescu, Razvan; Lee, Jeeyun.
Afiliación
  • Shui IM; Merck & Co., Inc, Rahway, New Jersey, USA irene.shui@merck.com.
  • Liu XQ; MSD China, Beijing, Shanghai, China.
  • Zhao Q; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Kim ST; Hematology and Oncology, Samsung Medical Center, Gangnam-gu, South Korea.
  • Sun Y; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Yearley JH; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Choudhury T; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Webber AL; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Krepler C; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Cristescu R; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Lee J; Hematology and Oncology, Samsung Medical Center, Gangnam-gu, South Korea.
J Immunother Cancer ; 10(7)2022 07.
Article en En | MEDLINE | ID: mdl-35793874
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article